From: Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children
Variables | Non AAC group | AAC group† | Pvalue |
---|---|---|---|
(n = 43) | (n = 24) | ||
Mean age (years) | 3.0 (0.2 ~ 10.6) | 3.3 (0.8 ~ 7.8) | 0.834 |
Male gender | 25 (58.1%) | 13 (54.2%) | 0.801 |
Duration of admission (days) | 6.0 (3.0 ~ 27.0) | 8.0 (4.0 ~ 36.0) | 0.059 |
Abdominal pain/vomiting | 24 (55.8%) | 13 (54.2%) | 1.000 |
Duration of fever (days) | 5.0 (3.0 ~ 9.0) | 5.0 (3.0 ~ 19.0) | 0.547 |
Typical Kawasaki disease | 23 (53.5%) | 16 (66.7%) | 0.317 |
Fever ≥ 5 days | 38 (88.4%) | 23 (95.8%) | 0.408 |
Dysmorphous skin rash | 36 (83.7%) | 22 (91.7%) | 0.472 |
Oral mucosal change | 33 (76.7%) | 19 (79.2%) | 0.820 |
Conjunctivitis | 39 (90.7%) | 17 (70.8%) | 0.046* |
Cervical lymphadenopathy | 28 (65.1%) | 19 (79.2%) | 0.228 |
Peripheral extremity change | 17 (39.5%) | 17 (70.8%) | 0.021* |
Duration till recovery of LFT (days) | 6.0 (1.0 ~ 43.0) | 6.0 (3.0 ~ 100.0) | 0.333 |
Frequency of IVIG infusion | 1.0 (0 ~ 2.0) | 1.0 (0 ~ 3.0) | 0.261 |